Pharmacological targeting of kinases MST1 and MST2 augments tissue repair and regeneration
0
Authors
Fuqin Fan
Fuqin Fan•Hao Liu•Dawang Zhou
Published
August 17, 2016
Abstract
Manipulation of the Hippo signaling pathway with a reversible and selective small-molecule inhibitor of Hippo kinase MST1/2 provides a therapeutic option for tissue injury and repair.